pregnant
PRENATAL DIAGNOSIS
Historical Context of Genetic Counseling
Origins of Genetic Counseling
Rooted in practices centuries before modern medicine.
Jewish scholars noted patterns of inheritance (Example: hemophilia).
Recommended against circumcision for male infants bleeding severely after birth; highlighted concern for maternal male relatives also possibly at risk.
Early Understanding of Genetic Conditions
Despite early observations, genetics largely overlooked by physicians.
Archibald Garrod (1909)
Introduced concept of inherited metabolic errors (e.g., alkaptonuria).
Proposed enzyme deficiencies as causes, hypothesizing autosomal recessive inheritance.
According to Garrod, genetic diseases were deemed rare and untreatable until mid-20th century breakthroughs.
Watson and Crick (1953):
Advancements in understanding DNA led to connections between chromosomal differences and diseases.
Tijo and Levan (1956)
Developed chromosome analysis techniques in human white blood cells.
Jerome Lejeune (1959)
Discovered an extra chromosome 21 in Down syndrome patients.
These studies culminated in the establishment of prenatal diagnostic methods.
Emergence of Prenatal Diagnosis
First Reported Instance (1968):
Detection of a genetic disorder via amniocentesis before the halfway mark of pregnancy.
Amniocentesis: Derived from Greek, combining "amnion" (fetal membrane) and "kentesis" (puncture).
Types of Prenatal Diagnostic Techniques:
Expansion of methods to enhance prenatal diagnosis.
Moral and Ethical Implications in Prenatal Diagnosis
Many families face moral dilemmas when presented with prenatal diagnosis options.
Availability of prenatal testing allows couples at high genetic risk to reconsider parenthood.
Case Study - Tay-Sachs Disease:
An autosomal recessive trait leading to severe brain degeneration and early death.
Detection through amniocentesis encourages informed parental choices, including pregnancy termination if affected fetus identified.
Routine Testing During Pregnancy
Blood Tests:
General tests include checking blood count, Rh factor, blood type, and tests for syphilis and rubella history.
Rh Factor Testing
Determines if expectant mother is Rh negative or Rh positive.
Risk arises during subsequent pregnancies if mother is Rh negative and baby is Rh positive. Antibody production can lead to complications:
Rhogam injection post-delivery prevents antibody development in future pregnancies.
Testing for harmful antibody levels is crucial in Rh negative women.
Hemoglobin Level Check
Assesses for anemia, a common concern during pregnancy.
If detected, iron supplements prescribed to maintain maternal and fetal health.
Syphilis Testing
Mandatory serology test. Early treatment prevents fetal abnormalities.
Rubella Testing
Determines maternal immunity to rubella; non-immune mothers advised to avoid exposure.
Immunization recommended post-pregnancy to protect future pregnancies.
Toxoplasmosis Testing
Tests for infection that could cause birth defects, primarily contracted from raw meats or cat feces.
Education on avoiding contact with kitty litter and uncooked meats for pregnant women.
Discussion with Healthcare Provider
Doctor inquiries to review personal and family medical histories. Encouragement for expectant mothers to ask questions.
Additional Testing Methods
Alpha-Fetoprotein Screening:
Detects potential neural tube defects or conditions like Down syndrome via Maternal Serum Alpha-Fetoprotein Screening (MSAFP).
Test performed during 15-16 weeks of pregnancy; abnormal levels may necessitate amniocentesis.
Amniocentesis
Involves needle insertion into the uterus for amniotic fluid sample.
Analyzes fetal condition and genetic disorders, particularly advised for women over age 35 due to elevated Down syndrome risk.
Miscarriage risk associated (1-2%); weighed against benefits of test results.
Chorionic Villus Sampling (CVS)
Samples chorion tissue for early genetic testing; performed earlier than amniocentesis (8-10 weeks).
Similar miscarriage risk; primarily for age-related Down syndrome testing.
PUBS Testing (Percutaneous Umbilical Blood Sampling)
Extracts fetal blood from umbilical cord for genetic assessment.
Highly accurate for detecting conditions, performed post-18 weeks of pregnancy.
Ultrasound (Sonography)
Utilized for fetal status, early diagnosis confirmations, multiple births identification, and assessing fetal growth and organ development.
HIV Testing
Detects antibodies for AIDS; critical awareness of transmission risks and follow-up testing for newborns.
Candidates for Prenatal Diagnosis
Focus is on couples at heightened risk for severe genetic disorders.
The probability of normal outcomes generally outweighs risks. Positive test results yield discussions on possible actions.
Statistics:
Roughly 100 women undergoing prenatal diagnostics find serious abnormalities in only 3-4 cases.
Negative outcomes don’t necessarily equate to the absence of defects due to many undetectable conditions remaining untested.
Amniocentesis Rates:
Annually ~15,000 procedures in the U.S., 85% for chromosomal analysis; 75% performed for maternal age considerations.
Genetic Counselor Role:
Critical in determining necessity for amniocentesis via comprehensive evaluations.
Additional Procedures
Fetoscopy
Allows visibility of fetus using a fetoscope inserted via abdominal incision with ultrasound guidance.
Performed around the 18th week for defect evaluation, blood sample collection, or skin biopsy.
X-rays
May necessitate during pregnancy; benefits versus risks evaluated carefully due to potential impacts on fetus.
Risks associated with electromagnetic radiation leading to cell/DNA harm.
Ongoing education regarding the use and risks of X-rays in pregnancy is essential.